Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 10 - Issue 10 - October 2013

Feature

Case Files By Dr. George
Nitinol-Constrained Balloon Dilatation to Minimize Vessel Trauma and Dissections in Peripheral Arterial Interventions
09/30/2013
The authors present a case of right superficial femoral artery calcified stenosis treated using rotational atherectomy with aspiration thrombectomy complicated by a small non-flow-limiting dissection of the treated segment.
The authors present a case of right superficial femoral artery calcified stenosis treated using rotational atherectomy with aspiration thrombectomy complicated by a small non-flow-limiting dissection of the treated segment.
The authors present a case of...
09/30/2013
Vascular Disease Management
Clinical Review
Atherectomy and Critical Limb Ischemia: A Treatment Approach for Severely Calcified Vessels
09/30/2013
Atherectomy devices excise, ablate, or modify calcified deposits and plaque, allowing compliance alteration of severely calcified vessels, rendering them more suitable for treatment with balloons and/or stents.
Atherectomy devices excise, ablate, or modify calcified deposits and plaque, allowing compliance alteration of severely calcified vessels, rendering them more suitable for treatment with balloons and/or stents.
Atherectomy devices excise,...
09/30/2013
Vascular Disease Management
Clinical Review
Arterial Deposition of Calcium and Outcomes of Peripheral Interventions: Is It Time to Redefine the Gold Standard?
09/30/2013
The authors address the most recent and relevant data that support these physiologic principles while challenging the status quo of peripheral interventions duirng a time of paradigm shift in which plaque and vessel wall modification, in...
The authors address the most recent and relevant data that support these physiologic principles while challenging the status quo of peripheral interventions duirng a time of paradigm shift in which plaque and vessel wall modification, in...
The authors address the most...
09/30/2013
Vascular Disease Management
Review
Atherectomy in the Treatment of Lower-Extremity Peripheral Artery Disease: A Critical Review
09/30/2013
Treatment with atherectomy for symptoms of lower extremity disease has now been shown to be effective in re-establishing blood flow with minimal vessel trauma and may serve as an alternative to a stent-first approach.
Treatment with atherectomy for symptoms of lower extremity disease has now been shown to be effective in re-establishing blood flow with minimal vessel trauma and may serve as an alternative to a stent-first approach.
Treatment with atherectomy for...
09/30/2013
Vascular Disease Management
Clinical Review
The AtheroMed Device: Early Experience With the First Hybrid Atherectomy Catheter
09/30/2013
This article reviews the Phoenix Atherectomy System, initial findings on the Phoenix catheter, and the system’s potential role in an exciting but crowded market segment.
This article reviews the Phoenix Atherectomy System, initial findings on the Phoenix catheter, and the system’s potential role in an exciting but crowded market segment.
This article reviews the Phoenix...
09/30/2013
Vascular Disease Management
Clinical Review
Clinical Overview of the Jetstream Atherectomy System
09/30/2013
The author describes the Jetstream Atherectomy System, its method of use, and providesa summary of the available clinical data regarding its use in the lower extremities. 
The author describes the Jetstream Atherectomy System, its method of use, and providesa summary of the available clinical data regarding its use in the lower extremities. 
The author describes the...
09/30/2013
Vascular Disease Management

Insights

Commentary
Lower-Limb Atherectomy: Defining the Current Landscape
09/30/2013
In this issue of Vascular Disease Management, we have brought together experts in the field of atherectomy to discuss the benefits and scientific data set with regard to all forms of atherectomy as a treatment modality for the lower limb.
In this issue of Vascular Disease Management, we have brought together experts in the field of atherectomy to discuss the benefits and scientific data set with regard to all forms of atherectomy as a treatment modality for the lower limb.
In this issue of Vascular...
09/30/2013
Vascular Disease Management

Meeting Materials

Abstracts
Abstracts From the 2013 Amputation Prevention Symposium
09/30/2013
Abstracts from AMP 2013.
Abstracts from AMP 2013.
Abstracts from AMP 2013.
09/30/2013
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management

Advertisement

Advertisement

October 2013 Volume 10 Issue 10

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement